Evonik expands powder biomaterials
Recently, Evonik announced the expansion of the production capacity of RESOMER powder biomaterials at its production base in Darmstadt, Germany. By using advanced solvent-free micronization technology, Evonik can produce customized powders with different particle sizes and material properties. With the increase in production capacity, Evonik also plans to expand its standard RESOMER powder product portfolio for medical devices to provide more customized material solutions for precision implants or medical aesthetic applications.
According to reports, RESOMER powder is suitable for implantable medical devices and strictly follows ISO 13485 and GMP compliance standards. The new micronization platform combines Evonik's expertise and deep experience in polymer design and processing technology as well as in a variety of applications.
Andreas Karau, global head of medical device solutions for Evonik's Healthcare business line, said:"With micronization technology, we can meet customer needs and provide them with the required grade of powder, thereby support customers to use innovative biomaterials to develop more applications in medical beauty and other medical fields."
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
Evonik to Close Two German Plants, Further Cutting Europe’s High-Purity Silicon Tetrachloride Capacity
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
Evonik Inaugurates New Speciality Alumina Plant in Japan, Bolstering Regional Growth Strategy
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
Evonik Launches Asia’s First Alkoxide Plant in Jurong Island
-
Evonik Converts Epoxy Hardener Production to 100% Renewable Electricity
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
Evonik Completes Shift to Green Electricity for Polybutadiene Production at its Marl, Germany, Plant
Recommend Reading
-
“An €8 Billion Loss, Yet a 25% Price Hike”: Wacker Chemie’s Contradictory Crisis—Survival Move or Desperate Gamble?
-
“The C Empire Unites!”: Wanhua Chemical’s $26.5 Billion Bet on Ethylene Integration—Is It Becoming China’s BASF or the New Global Olefins Overlord?
-
CordenPharma Invests €80 Million to Raise Sterile Injectable Capacity to 500 Million Units Annually
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
ZPC Plans 1.2 Million-Tonne PDH Unit, Setting a New Global Licensing Record
-
Premium Global Chemical Sourcing Requests (7-9Sep.,2026)
-
In the Fourth Quarter, China's Phenol Market Declined Significantly, Reaching a Five-Year Low
-
In 2025, China's hydrofluoric acid prices fluctuated upward; in 2026, the price level may continue to rise
-
October Sodium Metabisulfite Prices Decline
-
2025 Toluene Market Fluctuates Downward, 2026 Supply and Demand Competition Outlook